Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ioulia Vardaki
Observed names:
I. Vardaki,
Ioulia Vardaki (18669190)
Institutions:
The University of Texas MD Anderson Cancer Center,
Karolinska Institutet
Observed institutions:
Karolinska University Hospital,
The University of Texas MD Anderson Cancer Center,
Karolinska Institutet
ORCID:
0000-0002-0333-6496
Observed ORCID:
0000-0002-0333-6496
OpenAlex ID:
A5003950817
Periostin is identified as a putative metastatic marker in breast cancer-derived exosomes
2016
·
Ioulia Vardaki
, Sophia Ceder
, et al.
·
Oncotarget
·
76
PDF
Radium-223 Treatment Increases Immune Checkpoint Expression in Extracellular Vesicles from the Metastatic Prostate Cancer Bone Microenvironment
2021
·
Ioulia Vardaki
, Paul Corn
, et al.
·
Clinical Cancer Research
·
68
Metabolic and Signaling Functions of Cancer Cell-Derived Extracellular Vesicles
2016
·
P. Fonseca
, I. Vardaki
, et al.
·
International review of cytology
·
57
Caspase-3–dependent cleavage of Bcl-xL in the stroma exosomes is required for their uptake by hematological malignant cells
2016
·
Ioulia Vardaki
, Claire Sanchez
, et al.
·
Blood
·
40
Resistance to MET/VEGFR2 Inhibition by Cabozantinib Is Mediated by YAP/TBX5-Dependent Induction of FGFR1 in Castration-Resistant Prostate Cancer
2020
·
Filippos Koinis
, Paul Corn
, et al.
·
Cancers
·
32
PDF
Transcriptomic analysis of plasma exosomes provides molecular information of response to cabazitaxel treatment in men with metastatic castration‐resistant prostate cancer
2023
·
Ioulia Vardaki
, Seda Sabah Özcan
, et al.
·
The Prostate
·
8
PDF
ALK+ Anaplastic Large Cell Lymphoma (ALCL)-Derived Exosomes Carry ALK Signaling Proteins and Interact with Tumor Microenvironment
2022
·
Dimitrios Chioureas
, Janina Beck
, et al.
·
Cancers
·
7
PDF
74P Exosome profiling reveals prognostic markers of response to cabazitaxel in metastatic castration-resistant prostate cancer (mCRPC)
2021
·
I. Vardaki
, S. Sabah Ozcan
, et al.
·
Annals of Oncology
·
1
PDF
Supplementary Data from Radium-223 Treatment Increases Immune Checkpoint Expression in Extracellular Vesicles from the Metastatic Prostate Cancer Bone Microenvironment
2023
·
Ioulia Vardaki
, Paul Corn
, et al.
Supplementary Data from Radium-223 Treatment Increases Immune Checkpoint Expression in Extracellular Vesicles from the Metastatic Prostate Cancer Bone Microenvironment
2023
·
Ioulia Vardaki
, Paul Corn
, et al.
Supplementary Tables from Radium-223 Treatment Increases Immune Checkpoint Expression in Extracellular Vesicles from the Metastatic Prostate Cancer Bone Microenvironment
2023
·
Ioulia Vardaki
, Paul Corn
, et al.
Supplementary Data from Radium-223 Treatment Increases Immune Checkpoint Expression in Extracellular Vesicles from the Metastatic Prostate Cancer Bone Microenvironment
2023
·
Ioulia Vardaki
, Paul Corn
, et al.
PDF
Supplementary Tables from Radium-223 Treatment Increases Immune Checkpoint Expression in Extracellular Vesicles from the Metastatic Prostate Cancer Bone Microenvironment
2023
·
Ioulia Vardaki
, Paul Corn
, et al.
Supplementary Data from Radium-223 Treatment Increases Immune Checkpoint Expression in Extracellular Vesicles from the Metastatic Prostate Cancer Bone Microenvironment
2023
·
Ioulia Vardaki
, Paul Corn
, et al.
PDF
Data from Radium-223 Treatment Increases Immune Checkpoint Expression in Extracellular Vesicles from the Metastatic Prostate Cancer Bone Microenvironment
2023
·
Ioulia Vardaki
, Paul Corn
, et al.
Data from Radium-223 Treatment Increases Immune Checkpoint Expression in Extracellular Vesicles from the Metastatic Prostate Cancer Bone Microenvironment
2023
·
Ioulia Vardaki
, Paul Corn
, et al.
Molecular profiling of liquid biopsies from patients (pts) with bone metastatic castration-resistant prostate cancer (BM-CRPC) treated with radium-223 (RA-223) to reveal differential enrichment for markers that correlate with overall survival (OS).
2018
·
Paul Gettys Corn
, Sumit Kumar Subudhi
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
18
Citation count:
289
H-index:
7
I10-index:
5
Year
Topic
Type